Companies: 48,874 Total Market Cap: 132391982605079.18

Jiangsu Hengrui Medicine

SHA-600276

Healthcare Drug Manufacturers - General

Rank #438

Market Cap 48.89 B

Volume 35.02 M

Price 7.41

Change (%) 0.74%

Country or region

China

Jiangsu Hengrui Medicine's latest marketcap:

48.89 B

As of 05/19/2025, Jiangsu Hengrui Medicine's market capitalization has reached $48.89 B. According to our data, Jiangsu Hengrui Medicine is the 438th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	48.89 B
Revenue (ttm)	4.05 B
Net Income (ttm)	948.25 M
Shares Out	6.60 B
EPS (ttm)	0.15
Forward PE	46.50
Ex-Dividend Date	07/12/2024
Earnings Date	08/22/2025

Market Cap Chart

Data Updated: 05/19/2025

Jiangsu Hengrui Medicine's yearly market capitalization.

Jiangsu Hengrui Medicine has seen its market value drop from ¥591.75 B to ¥352.74 B since 2020, representing a total decrease of 40.39% and an annual compound decline rate (CAGR) of 11.13%.

Date	Market Cap	Change (%)
05/19/2025	¥352.74 B	12.33%
12/31/2024	¥291.86 B	1.48%
12/29/2023	¥287.60 B	17.03%
12/30/2022	¥245.74 B	-23.94%
12/31/2021	¥323.08 B	-45.4%
12/31/2020	¥591.75 B

Company Profile

About Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd. is a leading pharmaceutical company specializing in the research, development, manufacturing, and commercialization of drugs in China and internationally.

Key Focus Areas

Drug Development: Antineoplastic drugs, surgery medications, and treatments for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology.
Product Portfolio: Analgesia and anesthesia products, as well as contrast agents.

Additional Services

Technical consulting and training
Investment advisory services
Technology development and project management
Import and export of pharmaceutical products

Founded: 1970
Headquarters: Lianyungang City, China

Frequently Asked Questions

As of 05/19/2025, Jiangsu Hengrui Medicine (including the parent company, if applicable) has an estimated market capitalization of $48.89 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Jiangsu Hengrui Medicine global market capitalization ranking is approximately 438 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	China
Founded	1970
IPO Date	n/a
Employees	20,238
CEO	Hong Bin Dai
Sector	Healthcare
Industry	Drug Manufacturers - General
Address	No. 38, Huanghe Road Lianyungang City, Liaoning Province 222000 China
Website	https://www.hengrui.com